Improving Early Recognition of Tardive Dyskinesia

In this episode, the panel focuses on how enhancing patient and clinician education can improve early recognition of tardive dyskinesia. Experts emphasize presenting information in clear, accessible language and providing patients with medication guides to reinforce understanding of abnormal movements. They discuss how outpatient and ambulatory care pharmacists often have greater opportunities for in depth counseling, allowing patients to engage more fully in discussions about risks, expected timelines for treatment effects, and when to report emerging symptoms. The panel notes that response times for medications differ from the slower development of tardive dyskinesia, which highlights the need to help patients judge changes appropriately. Education is identified as a crucial tool that empowers patients to observe and communicate earlier signs of abnormal movements. By improving awareness and setting realistic expectations, pharmacists can support earlier detection, reduce delays in diagnosis, and help prevent progression of tardive dyskinesia.